Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01617161 · ClinicalTrials.gov registry record · NA
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
A NA study of Prostate Cancer, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 454
- Enrollment target
- 13
- Study locations
NCT01617161: Active NA study of Prostate Cancer, sponsored by Massachusetts General Hospital.
NCT01617161 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 454 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (25% lower). The trial reports 13 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01617161, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 454 participants
- Enrollment target
- 13
- Study locations
Study Summary
We are studying whether men being treated for prostate cancer have the same amount of side effects from either one of two different external radiation treatments: IMRT or PBT. With IMRT, a number of x-ray beams are used to shape the radiation to the prostate. PBT is another type of external radiation treatment for prostate cancer that is used in a few centers in the United States. Protons are tiny particles with positive charge that can be controlled to travel a certain distance and stop. PBT is precise like IMRT, but it uses proton beams instead of x-ray beams. IMRT and PBT aim to deliver most of the radiation to the prostate cancer while sparing surrounding tissues. Both IMRT and PBT have been used in the treatment of prostate cancer and are thought to be equally effective at curing prostate cancer. However, both treatments have also been shown to cause the potential side effects of radiation, including bowel, urinary and erectile problems. It is possible that side effect rates with PBT will be lower, the same, or even higher than with IMRT, but this has not been studied well to date. Though both of these radiation therapies have been used in the past to treat prostate cancer, there has never been a study that compares the effects of these two therapies to see which one has less side effects. In this research study, we are comparing IMRT to PBT to determine which therapy best minimizes the side effects of treatment.
Conditions Studied
Interventions
- RADIATION Intensity Modulated Radiation Therapy
- RADIATION Proton Beam Therapy
Study Locations (13)
Massachusetts
- Massachusetts General Hospital - Boston
- Mass General/North Shore Cancer Center - Danvers
New Jersey
- Rutgers Cancer Institute of New Jersey - New Brunswick
- Princeton ProCure Proton Therapy Center - Somerset
Florida
- University of Florida Health Proton Therapy Institute - Jacksonville
Illinois
- Northwestern Medicine Chicago Proton Center - Chicago
Maryland
- University of Maryland Medical Center - College Park
Minnesota
- Mayo Clinic - Rochester
Missouri
- Washington University - St Louis
Ohio
- University Hospital of Cleveland - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 454 participants |
| Start Date | 2012-07-25 |
| Est. Completion | 2030-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01617161
The ClinicalTrials.gov registry entry for NCT01617161 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 454 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (25% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Intensity Modulated Radiation Therapy is the first listed.
NCT01617161 reports 13 study locations spanning 11 distinct geographic areas - top geographies include Massachusetts, New Jersey, Florida.
Frequently Asked Questions
What is clinical trial NCT01617161 about?
NCT01617161 is a clinical study titled "Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer". We are studying whether men being treated for prostate cancer have the same amount of side effects from either one of two different external radiation treatments: IMRT or PBT. With IMRT, a number of x-ray beams are used to shape the radiation to the prostate. PBT is another type of external radiatio...
What is the current status of trial NCT01617161?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 454 participants. The study started on 2012-07-25. Estimated completion is 2030-12.
What conditions does trial NCT01617161 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT01617161?
The interventions under investigation include: Intensity Modulated Radiation Therapy (RADIATION), Proton Beam Therapy (RADIATION).
Who is sponsoring clinical trial NCT01617161?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01617161 being conducted?
This trial has 13 study locations across Florida, Illinois, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.